H
Hiroki Ueda
Researcher at Kyoto University
Publications - 46
Citations - 2430
Hiroki Ueda is an academic researcher from Kyoto University. The author has contributed to research in topics: Allotransplantation & Transplantation. The author has an hindex of 22, co-authored 39 publications receiving 2337 citations. Previous affiliations of Hiroki Ueda include Hyogo College of Medicine & Bausch & Lomb.
Papers
More filters
Journal ArticleDOI
Peripheral nerve regeneration across an 80-mm gap bridged by a polyglycolic acid (PGA)–collagen tube filled with laminin-coated collagen fibers: a histological and electrophysiological evaluation of regenerated nerves
Kazuya Matsumoto,Katsunori Ohnishi,Tetsuya Kiyotani,Takashi Sekine,Hiroki Ueda,Tatsuo Nakamura,Katsuaki Endo,Yasuhiko Shimizu +7 more
TL;DR: The authors' nerve conduit can guide peripheral nerve elongation and lead to favorable functional recovery across a wider nerve gap than previously reported artificial nerve conduits.
Journal ArticleDOI
Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2
TL;DR: The results demonstrate that a systematic control of BMP-2 delivery from gelatin microparticles can be achieved by altering the extent of basic gelatin crosslinking, and that controlled release relies on enzymatic degradation of the gelatin for controlled release.
Journal ArticleDOI
Dose Effect of Dual Delivery of Vascular Endothelial Growth Factor and Bone Morphogenetic Protein-2 on Bone Regeneration in a Rat Critical-Size Defect Model
Simon Young,Zarana S. Patel,James D. Kretlow,Matthew B. Murphy,Paschalia M. Mountziaris,L. Scott Baggett,Hiroki Ueda,Yasuhiko Tabata,John A. Jansen,Mark E. Wong,Antonios G. Mikos +10 more
TL;DR: The dose effect of dual delivery of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2 (BMP-2) on bone regeneration was investigated in a rat cranial critical-size defect and the addition of VEGF was unable to reverse this decrease in PBF, although improvements in the number of bridged defects did occur in some groups.
Journal ArticleDOI
Polyhydroxyalkanonate derivatives in current clinical applications and trials
Hiroki Ueda,Yasuhiko Tabata +1 more
TL;DR: The current clinical applications and trials of polyhydroxyalcanonate products are reviewed, which include biodegradability, biocompatibility, and toxicological safety.
Journal ArticleDOI
In Vitro and In Vivo Release of Vascular Endothelial Growth Factor from Gelatin Microparticles and Biodegradable Composite Scaffolds
TL;DR: The utility of gelatin microparticles and their composite scaffolds as delivery vehicles for the controlled release of VEGF for tissue engineering applications is demonstrated and kinetics were dependent on the extent of gelatin crosslinking.